Antimicrobial Susceptibility Testing Market Report 2026

Antimicrobial Susceptibility Testing Market Overview

• Antimicrobial Susceptibility Testing market size has reached to $4.65 billion in 2025 • Expected to grow to $6.01 billion in 2030 at a compound annual growth rate (CAGR) of 5.1% • Growth Driver: Antimicrobial Susceptibility Testing Market Driven By Rising Incidence Of Infectious Diseases • Market Trend: Rapid Detection Of Antimicrobial Susceptibility With Sysmex Corporation's Testing System • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antimicrobial Susceptibility Testing Market?

Antimicrobial susceptibility testing (AST) is a laboratory procedure done by clinical laboratory professionals to identify which antimicrobial specimen is specifically effective for individual patients. The antimicrobial susceptibility testing market consists of sales of antimicrobial susceptibility testing by entities (organizations, sole traders and partnerships) that are engaged in laboratory services that provide antimicrobial susceptibility testing. The main types of antimicrobial susceptibility testing (AST) procedures are antibacterial testing, antifungal testing, antiparasitic testing and others. Antifungal susceptibility testing refers to the ability of a specific organism to grow in vitro in the presence of a particular drug. AST products that are used in the testing are manual antimicrobial susceptibility testing products, automated laboratory instruments, and other consumables. These are used for diagnostics, drug discovery and development, and epidemiology. Antimicrobial susceptibility testing is used by hospitals and diagnostic centres, pharmaceutical and biotechnology companies, research and academic institutes, and clinical research organizations (CROs).

What Is The Antimicrobial Susceptibility Testing Market Growth Forecast?

The antimicrobial susceptibility testing market size is expected to see strong growth in the next few years. It will grow to $6.01 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing investments in rapid diagnostic technologies, rising adoption of ai-assisted laboratory analysis, expansion of surveillance programs for antimicrobial resistance, growing demand for point-of-care ast solutions, increasing focus on precision antimicrobial therapy. Major trends in the forecast period include increasing adoption of automated ast systems, rising demand for rapid diagnostic testing, growing integration of molecular and phenotypic methods, expansion of laboratory automation solutions, enhanced focus on antimicrobial resistance monitoring.

Global Antimicrobial Susceptibility Testing Market Segmentation

1) By Testing Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types 2) By Product: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables 3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications 4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs) Subsegments: 1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems 2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods 3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods 4) By Other Testing Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing

What Is The Driver Of The Antimicrobial Susceptibility Testing Market?

The rising incidence of infectious diseases globally contributed to the growth of the antimicrobial susceptibility testing market. Infectious diseases are caused by organisms like bacteria, viruses, fungi, and parasites. Diseases caused by bacteria are bacterial pneumonia, tuberculosis, the virus smallpox, AIDS, and others. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based national public health agency, in 2023, among 9,573 TB cases in persons for whom birth origin was known, 7,259 (76%) occurred among non-U.S.–born persons, an 18% increase compared with the 6,177 such cases reported in 2022. Therefore, the rising incidence of infectious diseases is driving the growth of the antimicrobial susceptibility testing industry.

Key Players In The Global Antimicrobial Susceptibility Testing Market

Major companies operating in the antimicrobial susceptibility testing market are BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Alifax Holding S.p.A., Synbiosis Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S

Global Antimicrobial Susceptibility Testing Market Trends and Insights

Major companies operating in the antimicrobial susceptibility testing market are developing innovative products, such as the First POC Testing System. First POC Testing System detects the presence or absence of bacteria and assesses the effectiveness of antimicrobials using urine samples from patients suspected of having urinary tract infections (UTIs). It is a significant development in the field of AST technologies and helps to accelerate the initiation of targeted antimicrobial therapy for patients with infections. For instance, in June 2023, Sysmex Corporation, a Japan-based company that manufactures reagents and equipment for clinical tests, including hematologic (blood) and immune tests, launched a testing system for rapid detection of antimicrobial susceptibility. Using a unique and proprietary microfluidic technology, the system delivers antimicrobial susceptibility testing (AST) results in as little as 30 minutes from the start of measurement, a significant reduction compared to the several days required for conventional AST.

What Are Latest Mergers And Acquisitions In The Antimicrobial Susceptibility Testing Market?

In May 2024, Pfizer, a US-based biopharmaceutical company, partnered with bioMérieux to strengthen antimicrobial stewardship through advanced diagnostics. The partnership aims to integrate bioMérieux’s advanced diagnostic technologies with Pfizer’s healthcare initiatives to enhance infection surveillance, support antimicrobial susceptibility testing, and promote appropriate and rational antibiotic use across Malawi’s public central hospitals. bioMérieux is a France-based company that offers a broad portfolio of microbial detection and antimicrobial susceptibility testing solutions that support evidence-based treatment decisions.

Regional Outlook

North America was the largest region in the antimicrobial susceptibility testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antimicrobial Susceptibility Testing Market?

The antimicrobial susceptibility testing (AST) market includes revenues earned by dilution susceptibility tests and disc diffusion susceptibility tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antimicrobial Susceptibility Testing Market Report 2026?

The antimicrobial susceptibility testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial susceptibility testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.